References

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 180 CE courses, most popular		$109Add to cart
Pick Your Courses
Up to 8 CE hours		$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Cardiac Biomarkers. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Cardiac Biomarkers (online CE course)
References

American Heart Association. "Cardiovascular Disease: A Costly Burden for America, Projections Through 2035." American Heart Association, 2017. https://www.heart.org/-/media/Files/Get-Involved/Advocacy/Burden-Report-Consumer-Report.pdf.
Arneson, W, Brickell, J, eds.Clinical Chemistry: A Laboratory Perspective. Philadelphia: FA Davis; 2007.
Carreiro-Lewandowski, E. "Update on cardiac markers." Lab Med. 2006;37:597-605.
D'Amore, PJ. "Evolution of C-reactive protein as a cardiac risk factor." Lab Med. 2005;36:234-238.
Dalia Adukauskiene et al. "Clinical relevance of high sensitivity C-reactive protein in cardiology." Medicina, Vol 52, Issue 1, 2016, pages 1-10.
Dotsenko, O, Chackathayil, J, Lip, GY. "Cardiac biomarkers: myths, facts and future horizons." Expert Review of Molecular Diagnostics. 2007;7:693-697.
European Society of Cardiology. "2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)." Eur Heart J, Volume 44, Issue 38, 7 Oct 2023, pages 3720–3826, https://doi.org/10.1093/eurheartj/ehad191.
Foley, K. "BNP: a novel biomarker." Advance for Medical Laboratory Professionals. August 25, 2008:9.
Fred S. Apple Paul O. Collinson and for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers. "Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays." Clinical Chemistry, January 2012, vol. 58 no. 1 54-61.
Gulati, M, Levy, P, Mukherjee, D, et al. "2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines." Circulation, Vol 144, 28 Oct 2021. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001030.
Gursahani, K, Brenner, B. "Cardiac Markers." eMedicine. Updated July 2021. Available at: http://emedicine.medscape.com/article/811905-print.
Kaplan, LA, Pesce, AJ, eds. Clinical Chemistry Theory, Analysis, Correlation. 5th ed. St. Louis, MO: Mosby Elsevier Science; 2010.
McDowell, J. "Reviewing the evidence for BNP, NT-proBNP testing." Clin Lab News. 2006;32:1, 3, 5.
Rifai, N, eds. Tietz Fundamentals of Clinical Chemistry. 9th ed. St. Louis, MO: Elsevier Saunders; 2023.
Rollins, G. "cTn and MI - what's the diagnosis?" Clin Lab News. 2009;35:1, 3-4.
Rollins, G. "The BNP debate." Clin Lab News. 2009;35:1,3-4.
Thomas J. Wang. "New cardiovascular risk factors exist, but are they clinically useful?" European Heart Journal, Vol 29, Issue 4, 1 February 2008, pages 441–444.
Thygesen, K, Alpert, JS, White, HD. "Universal definition of myocardial infarction." Circulation, 2007;116:2634-2653.